Brain metastases of neuroendocrine tumor with unknown primary location - Case report

Open access


Neuroendocrine tumors are tumors derived from the cells of the neuroendocrine system. The majority of metastases of neuroendocrine tumors occur in liver, lungs and bone. The brain is an uncommon site of metastasize for this type of tumor. The authors of this paper present a case of brain metastases of neuroendocrine tumor with undetermined primary location. The patient, a 35 yearsold man, was admitted in our clinic with headache, nausea, vomiting and a mild right facial paresis. Head CT scan and cerebral MRI identified two lesions: one larger lesion with mixed solid and cystic components located in the left basal ganglia and thalamus and a second cystic lesion located deep in the right parietal lobe. All complementary investigations (including thoracic CT scan and whole-body MRI) failed to reveal the primary tumor location. Due to the high vital-risks associated with the open surgical procedure, the patient and his family chose the less invasive procedure of stereotactic biopsy. Postoperatively the patient had no additional neurologic deficits, presenting only the initial mild right central facial paresis. The result of immunohistochemistry examination was cerebral metastases of neuroendocrine tumor. The patient was directed to the Institute of Oncology Fundeni for further investigations and therapeutically management. In conclusion, even if these are rare tumors which rarely metastasize in the brain, the neurosurgeons should take in consideration this pathology when they examine a patient with multiple cerebral lesions with unknown location of primary tumor.

1. Beasley MB, Thunnissen FB, Brambilla E, Hasleton P, Steele R, Hammar SP, Colby TV, Sheppard M, Shimosato Y, Koss MN, Falk R, Travis WD: Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol 2000; 31: 1255-1265

2. Brehar, F.M., Gorgan, R.M. Lisievici, M, Imageguided stereotactic biopsy of infiltrative, multicentric and deep-seated supratentorial cerebral gliomas, Romanian Neurosurgery 2012, Volume 19, Issue 2, Pages 87-95

3. Bushnell DL, Baum RP, Standard imaging techniques for neuroendocrine tumors, Endocrinol Metab Clin North Am. 2011 Mar;40(1):153-62

4. Gildenberg PL, Franklin P. Survey of CT-guided stereotactic surgery. Appl Neurophysiol 1985; 48:477-80

5. Greenberg Mark S, Handbook of Neurosurgery, Seventh Edition, N.Y., Thieme, 2010

6. Hlatky R, Suki D, Sawaya R: Carcinoid metastasis to the brain. Cancer 2004; 101: 2605-2613

7. Kayani I, Conry BG, Groves AM, Win T, Dickson J, Caplin M, Bomanji JB, A comparison of 68Ga- DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors, J Nucl Med. 2009 Dec;50(12):1927-32

8. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39:707-712

9. Maiuri F, Cappabianca P, Del Basso De Caro M, Esposito F: Single brain metastases of carcinoid tumors. J Neurooncol 2004; 66: 327-332

10. Marianne Pavel, Ashley Grossman, Rudolf Arnold et al, ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors, Neuroendocrinology 2010;91:326-332

11. Nakamura Y, Shimokawa S, Ishibe R, Ikee T, Taira A: Pulmonary carcinoid found in a patient who presented with initial symptoms of brain metastasis: report of a case. Surg Today 2001; 31: 510-512

12. Oberg K, Castellano D. Current knowledge on diagnosis and staging of neuroendocrine tumors. Cancer Metastasis Rev. 2011;30 Suppl 1:3-7

13. Olsen JO, Pozderac RV, Hinkle G, Hill T, O'Dorisio TM, Schirmer WJ, Ellison EC, O'Dorisio MS., Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan), Semin Nucl Med. 1995 Jul;25(3):251-61

14. Patchell RA, Posner JB: Neurologic complications of carcinoid. Neurology 1986; 36:745-741

15. Penz M, Kurtaran A, Vorbeck F, Oberhuber G, Raderer M: Case 2: myocardial metastases from a carcinoid tumor. J Clin Oncol 2000;18: 1596-1597

16. Porter DG, Chakrabarty A, McEvoy A, Bradford R: Intracranial carcinoid without evidence of extracranial disease. Neuropathol Appl Neurobiol 2000; 26: 298-3009

17. Ronald A. DeLellis, The Neuroendocrine System and Its Tumors, Am J Clin Pathol 2001;115 (Suppl 1):S5-S16

18. William D Travis, Anthony A Gal, Thomas V Colby, David S Klimstra, Roni Falk, Michael N Koss, MD Reproducibility of neuroendocrine lung tumor classification, Human Pathology, Volume 29, Issue 3 , Pages 272-279, March 1998

19. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB, One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States, J Clin Oncol. 2008;26(18):3063

20. Zulch K.J., Brain tumors. Their biology and pathology. Berlin: Springer-Verlag; 1986.

Romanian Neurosurgery

The Journal of Romanian Society of Neurosurgery

Journal Information


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 403 403 37
PDF Downloads 85 85 13